Evaluation of Serum STARD3 Levels in Patients With Breast and Prostate Cancer: A Case-Control Study.
The results suggest that STARD3 may play a role in the pathogenesis of both hormone-related cancers, although the mechanism remains unclear. Given the limited studies evaluating STARD3 in both breast and prostate cancers simultaneously, our findings contribute novel data to the literature and may guide future research into the diagnostic or prognostic potential of STARD3 in oncology.
Authors
- Şener Balas (ORCID: https://orcid.org/0000-0002-9154-3179)
- Nihat Karakoyunlu (ORCID: https://orcid.org/0000-0002-6680-9860)
- Nihal İnandıklıoğlu (ORCID: https://orcid.org/0000-0001-7137-3929)
- Alpaslan Öztürk (ORCID: https://orcid.org/0000-0003-4525-3477)
- Almila Nazlı Korucu (ORCID: https://orcid.org/0009-0001-9181-9032)
- Dilara Şevval Anasız (ORCID: https://orcid.org/0009-0006-8876-7469)
- Mine Büşra Bozkürk
Institutions
- Yozgat Bozok Üniversitesi (TR)
- Memorial Ankara Hospital (TR)
Publication Details
- Journal
- PubMed
- Published
- 2025-09-25
- DOI
- https://doi.org/10.4274/ejbh.galenos.2025.2025-5-1
- Primary Topic
- Cardiovascular Disease and Adiposity
- Type
- article
- Field-Weighted Citation Impact
- 0.00